Guy Macdonald
CIK 1296998 · President and Chief Executive · last filed 2025-06-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$329.9K
Companies
3
Total Filings
65
Lifetime Open-Market Net
-$7.67M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SCYX | Director | 78,000 | $4.23 | $329.9K | $145.6K | 33 | 2025-06-30 |
| TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted | President and Chief Executive | 0 | — | — | -$7.82M | 30 | 2020-07-29 |
| IDENIX PHARMACEUTICALS INC (IDIX) Delisted | Executive VP, Operations | — | — | — | $0 | 2 | 2007-06-04 |
Recent Filings · Page 5 of 7
65 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-08-03 | TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted | Mixed | — | -$395.1K | EDGAR |
| 2015-07-22 | TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted | Sell (S) | −15,000 | -$760.8K | EDGAR |
| 2015-07-06 | SCYX | Grant (A) | — | $0 | EDGAR |
| 2015-07-02 | TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted | Mixed | — | -$399.8K | EDGAR |
| 2015-06-05 | SCYX | Grant (A) | — | $0 | EDGAR |
| 2015-06-03 | TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted | Mixed | +13,913 | -$577.0K | EDGAR |
| 2015-05-13 | TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted | Mixed | — | -$671.4K | EDGAR |
| 2015-04-03 | SCYX | Grant (A) | — | $0 | EDGAR |
| 2015-03-27 | TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted | Exer (M) | +20,000 | $17.4K | EDGAR |
| 2015-03-04 | TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted | Mixed | — | -$317.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.